Fortical News
Unigene Announces Publication Of Initial Results Of Site-Directed ... - Medical News Today (press release)
Fortical®, Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. ...
Unigene to Present at the 20th Annual Roth Capital Partners Growth ... - FOXBusiness
Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. ...
Unigene to Present at the 20th Annual Roth Capital Partners Growth ... - FOXBusiness
Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. ...
Unigene Announces Publication of Initial Results of Site-Directed ... - FOXBusiness
Fortical(R), Unigene's nasal calcitonin product for the treatment of postmenopausal osteoporosis, received FDA approval and was launched in August 2005. ...
FDA Approves Improvement to Unigene’s Calcitonin Manufacturing Process - Business Wire (press release)
“In addition to reducing our manufacturing costs, these improvements should enable us to more easily increase our capacity if Fortical demand increases. ...
Many Osteoporosis Medications Prevent Fractures But Little ... - Medical News Today (press release)
Calcitonin is the active ingredient in Fortical, a nasal calcitonin treatment developed by Unigene and marketed by Upsher-Smith Laboratories. ...
UGNE: FDA Approves Modification for Key Enzyme in Fortical(R) - Trading Markets (press release)
... patented manufacturing process for calcitonin, the active ingredient in Fortical(R), Unigene's nasal spray product for the treatment of osteoporosis. ...
No Bones about It - Business Wire (press release)
Calcitonin is the active ingredient in Fortical, a nasal calcitonin treatment developed by Unigene and marketed by Upsher-Smith Laboratories. ...
UGNE: FDA Approves Modification for Key Enzyme in Fortical(R) - Trading Markets (press release)
... patented manufacturing process for calcitonin, the active ingredient in Fortical(R), Unigene's nasal spray product for the treatment of osteoporosis. ...
Unigene Expanding in China - NJBIZ
The United States’ rights to Fortical, Unigene’s nasal spray for the treatment of osteoporosis in post-menopausal women, are licensed to Upsher-Smith ...
Fortical RSS Feed